Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Nuclear Medicine Communications|May 9, 2009
Evaluation of different normalization procedures for the calculation of the standardized uptake value in therapy response monitoring studiesDennis Vriens, Lioe-Fee de Geus-Oei, Hanneke W van Laarhoven, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|September 25, 2018
A Randomized Study of Yoga for Fatigue and Quality of Life in Women with Breast Cancer Undergoing (Neo) Adjuvant ChemotherapyMiek C Jong, Inge Boers, Arjan P Schouten van der Velden, et al.
The Netherlands Journal of Medicine|October 23, 2020
Lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in Dutch patientsJ N H Timmer-Bonte, J Ouwerkerk, L M Faber, et al.
Geriatrics & Gerontology International|September 3, 2011
Encouraging results in older patients receiving chemotherapy: a retrospective analysis of treatment guideline adherence in daily practiceLinda Heijmen, Hanneke W M van Laarhoven, Cornelis J A Punt, et al.
International Journal of Cancer|April 22, 1992
In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical dataE F Smit, E G de Vries, H Timmer-Bosscha, et al.
British Journal of Cancer|July 2, 2009
Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumoursV Gregorc, A Santoro, E Bennicelli, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1994
Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assayS Withoff, E F Smit, G J Meersma, et al.
World Journal of Nuclear Medicine|February 2, 2013
(18)F-FLT-PET for Response Evaluation of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with Solid TumorsIngrid M E Desar, Rozemarie Gilles, Carla M L van Herpen, et al.
International Journal of Clinical Oncology|September 27, 2012
Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancerPatricia M M B Soetekouw, Johanna N H Timmer-Bonte, Miep A van der Drift, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Cost-effectiveness of adding granulocyte colony-stimulating factor to primary prophylaxis with antibiotics in small-cell lung cancerJohanna N H Timmer-Bonte, Eddy M M Adang, Hans J M Smit, et al.
Pageof 8